You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Essential thrombocythemia (ET), accelerated phase

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Essential Thrombocythemia Trial (Bomedemstat, Anagrelide, Busulfan)

Not yet recruiting
  • Essential Thrombocythemia
  • (no location specified)
Oct 6, 2023

Myelofibrosis (PMF), Post Essential Thrombocythemia Myelofibrosis (ET-MF), Post Polycythemia Vera Related Myelofibrosis (PV-MF)

Not yet recruiting
  • Myelofibrosis (PMF)
  • +2 more
  • New York, New York
    Ruttenberg Treatment Center
Apr 18, 2023

Essential Thrombocythemia Trial (Ropeginterferon alfa-2b-njft (P1101))

Not yet recruiting
  • Essential Thrombocythemia
  • Ropeginterferon alfa-2b-njft (P1101)
  • (no location specified)
Jul 28, 2022

Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV MF), Post-Essential Thrombocythemia Myelofibrosis

Terminated
  • Primary Myelofibrosis (PMF)
  • +2 more
  • Larkspur, California
  • +2 more
Nov 14, 2022

Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, ET-MF Trial in New York (Canakinumab)

Recruiting
  • Primary Myelofibrosis
  • +4 more
  • New York, New York
    Ruttenberg Treatment Center
Jul 18, 2022

Thrombocythemia, Essential Trial in San Antonio (IMG-7289)

Recruiting
  • Thrombocythemia, Essential
  • San Antonio, Texas
    Mays Cancer Center
Dec 14, 2021

The Role of Circ0014614 in the Formation and Development of ET

Recruiting
  • Primary Thrombocytosis
    • Guangzhou, Guangdong, China
      Department of Hematology,Nanfang Hospital, Southern Medical Univ
    Jun 18, 2023

    Acute Myeloid Leukemia, Essential Thrombocythemia, Myelodysplastic Syndrome Trial in Seattle (Decitabine, Ruxolitinib,

    Recruiting
    • Acute Myeloid Leukemia
    • +8 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Aug 18, 2022

    Myelofibrosis Trial in Worldwide (PXS-5505)

    Recruiting
    • Myelofibrosis
    • Birmingham, Alabama
    • +19 more
    Nov 28, 2022

    Primary Myelofibrosis Trial in Japan (Fedratinib)

    Recruiting
    • Primary Myelofibrosis
    • Suwa, Nagano, Japan
    • +25 more
    Jan 18, 2023

    Essential Tremor Trial (60 mg ulixacaltamide, Placebo)

    Not yet recruiting
    • Essential Tremor
    • 60 mg ulixacaltamide
    • Placebo
    • (no location specified)
    Oct 12, 2023

    Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis Trial in United States

    Completed
    Has Results
    • Primary Myelofibrosis
    • +2 more
    • Scottsdale, Arizona
    • +8 more
    Feb 10, 2022

    Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase, Primary Myelofibrosis, Secondary Myelofibrosis Trial in Houston

    Completed
    • Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase
    • +2 more
    • Laboratory Biomarker Analysis
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    May 27, 2022

    Essential Thrombocythemia Trial in Worldwide (IMG-7289)

    Active, not recruiting
    • Essential Thrombocythemia
    • Jacksonville, Florida
    • +25 more
    Apr 15, 2022

    Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, Post-polycythemia Vera Myelofibrosis Trial in Ipoh (NS-018,

    Recruiting
    • Primary Myelofibrosis
    • +2 more
    • Worcester, Massachusetts
    • +16 more
    Oct 31, 2022

    Polycythemia Vera (PV) Trial in Japan (P1101 (Ropeginterferon alfa-2b))

    Recruiting
    • Polycythemia Vera (PV)
    • P1101 (Ropeginterferon alfa-2b)
    • Toon-shi, Ehime, Japan
    • +5 more
    Jun 13, 2022

    Myelofibrosis Trial in Canton (Jaktinib Hydrochloride Tablet)

    Recruiting
    • Myelofibrosis
    • Jaktinib Hydrochloride Tablet
    • Canton, Ohio
      Site 01
    Aug 18, 2022

    Acute Myeloid Leukemia, Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis Trial in Farmington Hills, Sterling Heights

    Recruiting
    • Acute Myeloid Leukemia
    • +3 more
    • Farmington Hills, Michigan
    • +1 more
    Jun 5, 2021

    Myelofibrosis Due to and Following Polycythemia Vera Trial in United States (Ruxolitinib, Abemaciclib)

    Recruiting
    • Myelofibrosis Due to and Following Polycythemia Vera
    • Basking Ridge, New Jersey
    • +6 more
    Jan 26, 2023

    Study (MOST)

    Completed
    • MPN (Myeloproliferative Neoplasms)
      • Huntsville, Alabama
      • +115 more
      May 11, 2022

      Essential Thrombocythemia Trial in Tours (Anagrelide, Ruxolitinib (JAKAVI®), IFNa/ PegIFNa)

      Terminated
      • Essential Thrombocythemia
      • Tours, France
        FILO
      Jun 28, 2021

      Myelofibrosis, Essential Thrombocythemia, MPN Trial in New York (Peptide-based vaccine, Poly ICLC)

      Not yet recruiting
      • Myelofibrosis
      • +2 more
      • Peptide-based vaccine
      • Poly ICLC
      • New York, New York
        Icahn School of Medicine at Mount Sinai
      Jun 7, 2022

      Clonal Cytopenia of Undetermined Significance, Essential Thrombocythemia, Myelodysplastic Syndrome Trial in Los Angeles

      Not yet recruiting
      • Clonal Cytopenia of Undetermined Significance
      • +4 more
      • Biospecimen Collection
      • +6 more
      • Los Angeles, California
      • +1 more
      Oct 4, 2023

      Myelofibrosis; Anemia, Anemia, Myelofibrosis Trial in Canton, Gettysburg (DISC-0974)

      Recruiting
      • Myelofibrosis; Anemia
      • +5 more
      • Jacksonville, Florida
      • +6 more
      Jan 3, 2023

      Myelodysplastic/Myeloproliferative Tumor, Unclassifiable, Myelofibrosis Transformation in Essential Thrombocythemia,

      Recruiting
      • Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
      • +3 more
      • Houston, Texas
        M D Anderson Cancer Center
      Aug 18, 2022